Why Survival Rate Is Not the Best Way to Judge Cancer Spending

Monday, 13 April 2015

New York TimesWhy Survival Rate Is Not the Best Way to Judge Cancer SpendingNew York TimesIn 2012, a study published in Health Affairs argued that the big money we spend on health care in the United States is worth it, at least when it comes to cancer. The researchers found that the survival gains seen in the United States equated to more ...